Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical uses of nalidixic acid analogues: the fluoroquinolones.

× No keyword cloud information.

28 in total

1. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

Authors: J S Wolfson; D C Hooper
Journal: Antimicrob Agents Chemother Date: 1985-10 Impact factor: 5.191

2. Use of enoxacin in a patient with cystic fibrosis.

Authors: M G Miller; A T Ghoneim; J M Littlewood
Journal: Lancet Date: 1985-03-16 Impact factor: 79.321

3. Ciprofloxacin-resistant Pseudomonas.

Authors: C M Roberts; J Batten; M E Hodson
Journal: Lancet Date: 1985-06-22 Impact factor: 79.321

4. Investigations into the mechanism of action of the antibacterial agent norfloxacin.

Authors: G C Crumplin; M Kenwright; T Hirst
Journal: J Antimicrob Chemother Date: 1984-05 Impact factor: 5.790

5. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.

Authors: A L Barry; R N Jones
Journal: Antimicrob Agents Chemother Date: 1984-06 Impact factor: 5.191

6. A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea.

Authors: A Notowicz; E Stolz; B van Klingeren
Journal: J Antimicrob Chemother Date: 1984-09 Impact factor: 5.790

7. Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin.

Authors: S R Crider; S D Colby; L K Miller; W O Harrison; S B Kerbs; S W Berg
Journal: N Engl J Med Date: 1984-07-19 Impact factor: 91.245

8. Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.

Authors: D A Leigh; E C Smith; J Marriner
Journal: J Antimicrob Chemother Date: 1984-05 Impact factor: 5.790

9. Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.

Authors: D A Haase; G K Harding; M J Thomson; J K Kennedy; B A Urias; A R Ronald
Journal: Antimicrob Agents Chemother Date: 1984-10 Impact factor: 5.191

10. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.

Authors: M Rozenberg-Arska; A W Dekker; J Verhoef
Journal: J Infect Dis Date: 1985-07 Impact factor: 5.226

6 in total

Clinical uses of nalidixic acid analogues: the fluoroquinolones.

1. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

2. Use of enoxacin in a patient with cystic fibrosis.

3. Ciprofloxacin-resistant Pseudomonas.

4. Investigations into the mechanism of action of the antibacterial agent norfloxacin.

5. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.

6. A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea.

7. Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin.

8. Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.

9. Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.

10. Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.

Review 1. Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

2. Decreased sensitivity of Neisseria gonorrhoeae to quinolone compounds.

3. Intestinal elimination of ofloxacin enantiomers in the rat: evidence of a carrier-mediated process.

Review 4. Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Review 5. Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Review 6. Fluoroquinolone antimicrobial agents.